PIMREG and endothelial dysfunction: We have recently shown that Cat-S is an upstream inducer of inflammation-related endothelial dysfunction by cleaving the extracellular domain of the protease-activated receptor (PAR)-2 on the luminal membranes of vascular endothelial cells5.